Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: Clinical features, diagnostic testing and survival

Alchanatis, 2001, Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics, Respiration, 68, 566, 10.1159/000050574 Andersen, 2012, Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test, Respiratory Medicine, 106, 875, 10.1016/j.rmed.2012.02.015 Andersen, 2012, Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease, Journal of Heart Lung Transplantation, 31, 373, 10.1016/j.healun.2011.11.020 Arcasoy, 2001, Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation, Chest, 120, 873, 10.1378/chest.120.3.873 Atkins, 2009, Guidelines for the diagnosis and treatment of canine chronic valvular heart disease, Journal of Veterinary Internal Medicine, 23, 1142, 10.1111/j.1939-1676.2009.0392.x Barbera, 2015, Management of pulmonary hypertension in patients with chronic lung disease, Current Hypertension Reports, 17, 62, 10.1007/s11906-015-0574-9 Baughman, 2010, Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation, Chest, 138, 1078, 10.1378/chest.09-2002 Berniker, 2016, Imaging of small airway diseases, Radiologic Clinics of North America, 54, 1165, 10.1016/j.rcl.2016.05.009 Blanco, 2010, Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension, American Journal of Respiratory and Critical Care Medicine, 181, 270, 10.1164/rccm.200907-0988OC Borgarelli, 2015, Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease, Journal of Veterinary Internal Medicine, 29, 569, 10.1111/jvim.12564 Bottero, 2013, Clinical evaluation and endoscopic classification of bronchomalacia in dogs, Journal of Veterinary Internal Medicine, 27, 840, 10.1111/jvim.12096 Brewis, 2015, Severe pulmonary hypertension in lung disease: phenotypes and response to treatment, The European Respiratory Journal, 46, 1378, 10.1183/13993003.02307-2014 Chaouat, 2008, Pulmonary hypertension in COPD, The European Respiratory Journal, 32, 1371, 10.1183/09031936.00015608 Chatila, 2008, Comorbidities in chronic obstructive pulmonary disease, Proceedings of the American Thoracic Society, 5, 549, 10.1513/pats.200709-148ET Chebib, 2018, Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups, Pulmonary Circulation, 8, 10.1177/2045894018775056 Collard, 2007, Sildenafil improves walk distance in idiopathic pulmonary fibrosis, Chest, 131, 897, 10.1378/chest.06-2101 Corte, 2010, The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease, Respirology, 15, 1226, 10.1111/j.1440-1843.2010.01860.x Denton, 1997, Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis, British Journal of Rheumatology, 36, 239, 10.1093/rheumatology/36.2.239 Edwards, 2015, Imaging of small airways and emphysema, Clinics in Chest Medicine, 36, 335, 10.1016/j.ccm.2015.02.013 Falk, 2008, Cardiac disease in chronic obstructive pulmonary disease, Proceedings of the American Thoracic Society, 5, 543, 10.1513/pats.200708-142ET Finlay, 1983, Cardiac output, pulmonary hypertension, hypoxaemia and survival in patients with chronic obstructive airways disease, European Journal of Respiratory Diseases, 64, 252 Fisher, 2009, Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension, American Journal of Respiratory and Critical Care Medicine, 179, 615, 10.1164/rccm.200811-1691OC Galie, 2016, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, Revisita Espanola de Cardiologia (English Edition), 69, 177, 10.1016/j.rec.2016.01.002 Gold, 2016, Pulmonary function testing, 407 Hamada, 2007, Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis, Chest, 131, 650, 10.1378/chest.06-1466 Harris, 2017, Standardization of a videofluoroscopic swallow study protocol to investigate dysphagia in dogs, Journal of Veterinary Internal Medicine, 31, 383, 10.1111/jvim.14676 Hoeper, 2009, Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension, Journal of the American College of Cardiology, 54, S85, 10.1016/j.jacc.2009.04.008 Hurdman, 2012, ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a referral centre, The European Respiratory Journal, 39, 945, 10.1183/09031936.00078411 Jaffey, 2017, Vasoproliferative process resembling pulmonary capillary hemangiomatosis in a cat, BMC Veterinary Research, 13, 72, 10.1186/s12917-017-0984-9 Johnson, 1999, Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992-1996, Journal of Veterinary Internal Medicine, 13, 440 Keene, 2019, ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs, Journal of Veterinary Internal Medicine, 33, 1127, 10.1111/jvim.15488 Kellihan, 2010, Pulmonary hypertension in dogs: diagnosis and therapy. The Veterinary Clinics of North America, Small Animal Practice, 40, 623, 10.1016/j.cvsm.2010.03.011 Kellihan, 2011, NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension, Journal of Veterinary Cardiology, 13, 171, 10.1016/j.jvc.2011.04.003 Kellihan, 2012, Pulmonary hypertension in canine degenerative mitral valve disease, Journal of Veterinary Cardiology, 14, 149, 10.1016/j.jvc.2012.01.001 Kellihan, 2015, Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014, Journal of Veterinary Cardiology, 17, 182, 10.1016/j.jvc.2015.04.002 Kellum, 2007, Sildenafil citrate therapy in 22 dogs with pulmonary hypertension, Journal of Veterinary Internal Medicine, 21, 1258, 10.1111/j.1939-1676.2007.tb01947.x Klinger, 2016, Group III Pulmonary Hypertension: pulmonary hypertension associated with lung disease: epidemiology, pathophysiology, and treatments, Cardiology Clinics, 34, 413, 10.1016/j.ccl.2016.04.003 Koster, 2016, A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese, Veterinary Medicine, 7, 19 Leuchte, 2006, Brain natriuretic peptide is a prognostic parameter in chronic lung disease, American Journal of Respiratory and Critical Care Medicine, 173, 744, 10.1164/rccm.200510-1545OC Lopez, 2006, Chronic obstructive pulmonary disease: current burden and future projections, The European Respiratory Journal, 27, 397, 10.1183/09031936.06.00025805 Mercier, 2011, Influence of age on bronchoscopic findings in healthy beagle dogs, The Veterinary Journal, 187, 225, 10.1016/j.tvjl.2009.12.007 Morita, 2018, Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi, The Journal of Veterinary Medical Science, 80, 939, 10.1292/jvms.17-0716 Nadrous, 2005, Pulmonary hypertension in patients with idiopathic pulmonary fibrosis, Chest, 128, 2393, 10.1378/chest.128.4.2393 Ocal, 2016, Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects, Respiratory Medicine, 119, 109, 10.1016/j.rmed.2016.08.027 Okine, 2018, Diagnosis of pneumocystis pneumonia in a 2-year-old King Charles Cavalier Spaniel using the polymerase chain reaction, Veterinary Clinical Pathology, 47, 146, 10.1111/vcp.12563 Pate, 2016, Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation, Bone Marrow Transplant, 51, 310, 10.1038/bmt.2015.248 Prins, 2016, World Health Organization group I pulmonary hypertension: epidemiology and pathophysiology, Cardiology Clinics, 34, 363, 10.1016/j.ccl.2016.04.001 Pyle, 2004, Pulmonary hypertension and cardiovascular sequelae in 54 dogs, The International Journal of Applied Research in Veterinary Medicine, 2, 99 Rietema, 2008, Sildenafil treatment in COPD does not affect stroke volume or exercise capacity, The European Respiratory Journal, 31, 759, 10.1183/09031936.00114207 Rishniw, 2000, Evaluation of four 2-dimensional echocardiographic methods of assessing left atrial size in dogs, Journal of Veterinary Internal Medicine, 14, 429, 10.1111/j.1939-1676.2000.tb02252.x Roels, 2017, Comparison between sedation and general anesthesia for high resolution computed tomographic characterization of canine idiopathic pulmonary fibrosis in West Highland white terriers, Veterinary Radiology & Ultrasound, 58, 284, 10.1111/vru.12481 Sajkov, 2002, Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea, American Journal of Respiratory and Critical Care Medicine, 165, 152, 10.1164/ajrccm.165.2.2010092 Schiborra, 2018, CT findings in Pneumocystis carinii pneumonia in five dogs, Journal of Small Animal Practice, 59, 508, 10.1111/jsap.12833 Seeger, 2013, Pulmonary hypertension in chronic lung diseases, Journal of the American College of Cardiology, 62, D109, 10.1016/j.jacc.2013.10.036 Serres, 2006, Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005), Journal of the American Veterinary Medical Association, 229, 1772, 10.2460/javma.229.11.1772 Serres, 2007, Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension, Journal of Veterinary Internal Medicine, 21, 1280, 10.1111/j.1939-1676.2007.tb01950.x Simonneau, 2013, Updated clinical classification of pulmonary hypertension, Journal of the American College of Cardiology, 62, D34, 10.1016/j.jacc.2013.10.029 Soydan, 2015, Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension, Journal of Veterinary Cardiology, 17, 13, 10.1016/j.jvc.2014.10.004 Stadler, 2011, Computed tomographic imaging of dogs with primary laryngeal or tracheal airway obstruction, Veterinary Radiology & Ultrasound, 52, 377, 10.1111/j.1740-8261.2011.01816.x Tai, 2013, Echocardiographic assessment of right heart indices in dogs with elevated pulmonary artery pressure associated with chronic respiratory disorders, heartworm disease, and chronic degenerative mitral valvular disease, Veterinarni Medicina, 58, 613, 10.17221/7180-VETMED Thierry, 2017, Further characterization of computed tomographic and clinical features for staging and prognosis of idiopathic pulmonary fibrosis in West Highland white terriers, Veterinary Radiology & Ultrasound, 58, 381, 10.1111/vru.12491 Thomas, 1993, Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine, Journal of Veterinary Internal Medicine, 7, 247, 10.1111/j.1939-1676.1993.tb01015.x Toom, 2016, Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog, Acta Veterinaria Scandinavica, 58, 46, 10.1186/s13028-016-0228-1 Vezzosi, 2018, Echocardiographic evaluation of the right ventricular dimension and systolic function in dogs with pulmonary hypertension, Journal of Veterinary Internal Medicine, 32, 1541, 10.1111/jvim.15253 Vezzosi, 2018, Echocardiographic evaluation of the right atrial area index in dogs with pulmonary hypertension, Journal of Veterinary Internal Medicine, 32, 42, 10.1111/jvim.15035 Visser, 2016, Diagnostic value of right pulmonary artery distensibility index in dogs with pulmonary hypertension: comparison with Doppler echocardiographic estimates of pulmonary arterial pressure, Journal of Veterinary Internal Medicine, 30, 543, 10.1111/jvim.13911 Zielinski, 1998, Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study, Chest, 113, 65, 10.1378/chest.113.1.65 Zimmermann, 2014, Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors, Respirology, 19, 700, 10.1111/resp.12294